Skip to content
SLETOR
ClosedChemical products

UKRI-3971 MRC NATA Purchase of Oligonucleotide Synthesis[E11]

Swindon, United KingdomUK Research and Innovation[E1]

Sign in to track this bidAdd deadline to calendar

In plain English

What they want
UKRI-MRC wishes to establish a Contract for the provision of Oligonucleotide Synthesis. The aim of the tender exercise is to identify an appropriate provider of ASO and siRNA oligonucleotides for NATA.
Who can bid
No restrictions are stated in the notice data. The tender documents may set more.
Deadline
Buyer's deadline: 30 Aug 2024, 17:00 UTC+1. UTC: 30 Aug 2024, 16:00 UTC.
Published 31 Jul 2024.
Value
GBP 900,000
Buyer
UK Research and InnovationSee what else this buyer buys and when.
How to apply
Through the buyer's official process. Open the original notice on UK Contracts Finder (OCDS) (opens in a new tab) ↗
Tender documents

The tender documents for this notice are on the buyer's own portal, usually behind a free supplier registration. We link to them and do not fetch them, so the report is based on the notice only.

This opportunity is closed and its deadline has passed. Reports are not available for it.

Deadline[E4]
30 Aug 2024, 17:00 UTC+1
Value[E12]
GBP 900,000
Published[E9]
31 Jul 2024
Procedure[E8]
Open procedure
Source
UK Contracts Finder (OCDS) (opens in a new tab)
Last checked
4 hours ago

About the requirement

From the notice

UKRI-MRC wishes to establish a Contract for the provision of Oligonucleotide Synthesis. The aim of the tender exercise is to identify an appropriate provider of ASO and siRNA oligonucleotides for NATA.[E5]

Eligibility and requirements

  • ConditionDelivery location: South East, United Kingdom.[E6]
  • The notice data states no restriction on who may bid. Exclusion grounds and selection criteria in the tender documents still apply.

Risks and unknowns

  • UnknownWe read the published notice, not the full tender documents.

Updates

  1. First seen · 28 Oct 2026, 14:02 UTC

    The deadline (2024-08-30T16:00:00.000Z) has passed.

    Source document dd767970-1a3a-4fa1-b208-6e7b195dfc46-772625

Evidence

12 facts

Every fact on this page comes from the published notice. Each entry shows the document and the field it was read from.

  1. E1

    The buyer is UK Research and Innovation.

    Document dd767970-1a3a-4fa1-b208-6e7b195dfc46-772625, field /buyer/name, read 28 Oct 2026, 14:02 UTC · source (opens in a new tab)

  2. E2

    The notice is classified under CPV 24956000 (Peptones and protein substances).

    Document dd767970-1a3a-4fa1-b208-6e7b195dfc46-772625, field /tender/classification/id, read 28 Oct 2026, 14:02 UTC · source (opens in a new tab)

  3. E3

    Contracts Finder publishes United Kingdom procurement.

    “UK”

    Document dd767970-1a3a-4fa1-b208-6e7b195dfc46-772625, field /tender, read 28 Oct 2026, 14:02 UTC · source (opens in a new tab)

  4. E4

    Tenders must be submitted by 30 Aug 2024, 17:00 UTC+01:00.

    “2024-08-30T17:00:00+01:00”

    Document dd767970-1a3a-4fa1-b208-6e7b195dfc46-772625, field /tender/tenderPeriod/endDate, read 28 Oct 2026, 14:02 UTC · source (opens in a new tab)

  5. E5

    The buyer describes the requirement in the notice.

    “UKRI-MRC wishes to establish a Contract for the provision of Oligonucleotide Synthesis. The aim of the tender exercise is to identify an appropriate provider of ASO and siRNA oligonucleotides for NATA.”

    Document dd767970-1a3a-4fa1-b208-6e7b195dfc46-772625, field /tender/description, read 28 Oct 2026, 14:02 UTC · source (opens in a new tab)

  6. E6

    Delivery location: South East, United Kingdom.

    Document dd767970-1a3a-4fa1-b208-6e7b195dfc46-772625, field /tender/items/0/deliveryAddresses/0, read 28 Oct 2026, 14:02 UTC · source (opens in a new tab)

  7. E7

    This is a call for competition. Suppliers can respond.

    “tender”

    Document dd767970-1a3a-4fa1-b208-6e7b195dfc46-772625, field /tag, read 28 Oct 2026, 14:02 UTC · source (opens in a new tab)

  8. E8

    The procedure is: Open procedure.

    Document dd767970-1a3a-4fa1-b208-6e7b195dfc46-772625, field /tender/procurementMethodDetails, read 28 Oct 2026, 14:02 UTC · source (opens in a new tab)

  9. E9

    The notice was published on 31 Jul 2024.

    “2024-07-31T09:35:03+01:00”

    Document dd767970-1a3a-4fa1-b208-6e7b195dfc46-772625, field /tender/documents/0/datePublished, read 28 Oct 2026, 14:02 UTC · source (opens in a new tab)

  10. E10

    Contracts Finder gives the tender status as active.

    Document dd767970-1a3a-4fa1-b208-6e7b195dfc46-772625, field /tender/status, read 28 Oct 2026, 14:02 UTC · source (opens in a new tab)

  11. E11

    The notice is titled "UKRI-3971 MRC NATA Purchase of Oligonucleotide Synthesis".

    Document dd767970-1a3a-4fa1-b208-6e7b195dfc46-772625, field /tender/title, read 28 Oct 2026, 14:02 UTC · source (opens in a new tab)

  12. E12

    The stated value is GBP 900,000.

    “900000 GBP”

    Document dd767970-1a3a-4fa1-b208-6e7b195dfc46-772625, field /tender/value/amount, read 28 Oct 2026, 14:02 UTC · source (opens in a new tab)

Contains public sector information from Contracts Finder, licensed under the Open Government Licence v3.0. Data licence: Open Government Licence v3.0 (opens in a new tab). Personal contact details in notices are not stored or shown.